ARYA Atherosclerosis

Scope & Guideline

Connecting researchers to elevate cardiovascular medicine.

Introduction

Immerse yourself in the scholarly insights of ARYA Atherosclerosis with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1735-3955
PublisherISFAHAN UNIV MEDICAL SCIENCES, ISFAHAN CARDIOVASCULAR RES CENTER
Support Open AccessNo
CountryIran
TypeJournal
Converge2007, from 2011 to 2024
AbbreviationARYA ATHEROSCLER / ARYA Atheroscler.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 81465-1148, ISAFAHAN, REPUBLIC ISLAMIC 00000, IRAN

Aims and Scopes

ARYA Atherosclerosis focuses on advancing knowledge in cardiovascular health, disease prevention, diagnosis, and treatment methodologies. The journal encompasses a wide range of topics related to atherosclerosis and cardiovascular diseases, employing various research methodologies to address clinical and epidemiological questions.
  1. Cardiovascular Disease Epidemiology:
    Research in this area examines the prevalence, risk factors, and outcomes associated with cardiovascular diseases, utilizing systematic reviews and meta-analyses to synthesize data from various populations.
  2. Innovative Therapeutic Approaches:
    The journal publishes studies on novel treatments and interventions in cardiovascular care, including pharmacological trials and non-pharmacological strategies such as rehabilitation and lifestyle modifications.
  3. Diagnostic Techniques and Biomarkers:
    Focused on the development and validation of diagnostic tools and biomarkers for early detection and risk stratification in cardiovascular diseases, enhancing clinical decision-making.
  4. Interventional Cardiology:
    Research in this scope covers advancements in interventional techniques such as percutaneous coronary interventions and their outcomes, emphasizing procedural efficacy and patient safety.
  5. Clinical Guidelines and Practice Standards:
    The journal highlights the development of clinical practice guidelines and assessments of their implementation, aiming to improve cardiovascular care and patient outcomes.
  6. Impact of Comorbidities on Cardiovascular Health:
    Exploration of how comorbid conditions, such as diabetes and hypertension, influence cardiovascular disease progression and management strategies.
Recent publications in ARYA Atherosclerosis reflect evolving interests in emerging themes within cardiovascular research, showcasing a shift towards contemporary and relevant topics in the field.
  1. Impact of Lifestyle Factors on Cardiovascular Health:
    Increasing focus on how lifestyle modifications, such as exercise, diet, and smoking cessation, influence cardiovascular outcomes, reflecting a growing recognition of preventative care.
  2. Cardiovascular Effects of COVID-19:
    Emerging studies addressing the cardiovascular implications of COVID-19, including long-term effects on heart health and management strategies during the pandemic.
  3. Advanced Imaging Techniques:
    A trend towards utilizing advanced echocardiographic and imaging modalities to assess cardiac function and structure, underscoring the importance of precision medicine in cardiovascular diagnostics.
  4. Psychosocial Aspects of Cardiovascular Disease:
    Research investigating the psychological and social factors affecting cardiovascular patients, including mental health interventions and their impact on recovery and outcomes.
  5. Quality of Care and Healthcare Systems:
    An increasing emphasis on assessing the quality of cardiovascular care and the effectiveness of healthcare systems in managing cardiovascular diseases, aiming to enhance patient outcomes.

Declining or Waning

Despite the journal's robust focus on atherosclerosis and cardiovascular health, certain themes appear to be declining in prominence over the recent years. This section outlines those waning areas of research.
  1. Genetic Studies in Cardiovascular Disease:
    While genetic factors remain important in cardiovascular research, the frequency of publications focused specifically on genetic associations and polymorphisms has diminished, possibly due to a shift towards more clinical and intervention-focused studies.
  2. Traditional Risk Factor Assessments:
    There is a noticeable decrease in studies solely dedicated to traditional cardiovascular risk factors such as cholesterol levels and hypertension, indicating a broader focus on integrated approaches and novel risk factors.
  3. Historical Perspectives on Cardiovascular Interventions:
    Research examining historical approaches and long-term outcomes of older cardiovascular interventions appears to be waning, as the journal shifts towards contemporary practices and innovations.

Similar Journals

Korean Circulation Journal

Pioneering Insights in Cardiology and Cardiovascular Medicine.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Open Cardiovascular Medicine Journal

Transforming Cardiovascular Care through Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: Frequency: 1 issue/year

Open Cardiovascular Medicine Journal is a notable scholarly platform published by Bentham Science Publishers Ltd, dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. With an E-ISSN of 1874-1924, this open-access journal has been a beacon for researchers and clinicians alike since its inception in 2009. Acting as a conduit for the latest research findings, the journal fosters interdisciplinary collaboration and innovation, contributing to the overall progress in cardiovascular health. Although currently ranked in the 26th percentile among cardiology journals, it emphasizes high-quality, peer-reviewed articles that uphold the rigorous standards of academic integrity. The journal also benefits from a robust editorial team and an array of publication options, ensuring accessibility and visibility of crucial cardiovascular research. As it continues its journey through 2023 and beyond, Open Cardiovascular Medicine Journal remains essential for anyone invested in the challenges and advancements within the cardiovascular domain.

Revista Portuguesa de Cardiologia

Empowering the fight against heart disease through open access research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Indian Heart Journal

Championing Open Access to Cardiovascular Insights
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

World Journal of Cardiology

Empowering the future of cardiovascular science.
Publisher: BAISHIDENG PUBLISHING GROUP INCISSN: 1949-8462Frequency: 12 issues/year

World Journal of Cardiology, published by BAISHIDENG PUBLISHING GROUP INC, stands out as a pivotal resource in the field of cardiology and cardiovascular medicine. With an ISSN of 1949-8462, this journal serves a global audience, promoting knowledge dissemination and collaboration among researchers, healthcare professionals, and students dedicated to advancing cardiovascular health. The journal demonstrates its credibility and impact in the field by achieving a respectable Q2 ranking in the 2023 category of Cardiology and Cardiovascular Medicine. Notably, it is listed in the Scopus database, ranking #189 out of 387 journals, placing it in the 51st percentile, which underscores its relevance and contribution to contemporary cardiovascular research. Although it operates under a subscription model, the journal provides diverse access options, ensuring that critical findings reach a wide audience. Through its comprehensive scope and commitment to publishing high-quality articles, the World Journal of Cardiology plays a vital role in shaping the future of cardiovascular science, making it an invaluable asset for those involved in this essential discipline.

TRENDS IN CARDIOVASCULAR MEDICINE

Pioneering Insights for a Healthier Heart
Publisher: ELSEVIER SCIENCE LONDONISSN: 1050-1738Frequency: 8 issues/year

TRENDS IN CARDIOVASCULAR MEDICINE, published by Elsevier Science London, stands at the forefront of the cardiology field, with a commendable Q1 ranking in the category of Cardiology and Cardiovascular Medicine. Since its inception in 1991, this esteemed journal has provided a vital platform for disseminating cutting-edge research and innovative clinical practices, reflecting the dynamic developments in cardiovascular health. With an impact factor positioning it among the top 3% in its category, TRENDS IN CARDIOVASCULAR MEDICINE is essential reading for researchers, healthcare professionals, and students pursuing the latest advancements and evidence-based approaches in cardiology. Although this journal does not currently operate under an open-access model, its rich array of content encompasses a variety of topics from clinical studies to reviews, ensuring readers stay informed on the pivotal trends that shape cardiovascular medicine. This commitment to excellence underscores the journal's role as a premier resource for anyone dedicated to improving cardiovascular health.

REVISTA ESPANOLA DE CARDIOLOGIA

Advancing Cardiovascular Knowledge with Every Issue
Publisher: EDICIONES DOYMA S AISSN: Frequency: 12 issues/year

REVISTA ESPANOLA DE CARDIOLOGIA is a premier journal dedicated to the dynamic field of cardiology, published by EDICIONES DOYMA S A in Barcelona, Spain. With an impressive Q1 status in the Medicine (miscellaneous) category for 2023, this journal is recognized for its significant contributions to cardiovascular research, evidenced by its rank of #61 out of 387 in the Scopus database, placing it within the top 16% of journals in its field. Covering a broad range of topics within cardiology, the journal aims to disseminate high-quality research, clinical studies, and educational content, fostering knowledge sharing among researchers, clinicians, and students alike. While it does not currently offer open access, the journal maintains a commitment to advancing cardiovascular health through rigorous peer-reviewed articles. With a publication history that spans from 2013 to 2024, REVISTA ESPANOLA DE CARDIOLOGIA is an essential resource for those seeking to stay at the forefront of cardiology advancements and practices.

HEART AND VESSELS

Elevating Standards in Cardiovascular Research and Practice
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Nature Reviews Cardiology

Advancing Cardiovascular Knowledge for a Healthier Future
Publisher: NATURE PORTFOLIOISSN: 1759-5002Frequency: 12 issues/year

Nature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.

Cardiovascular Therapeutics

Transforming Research into Therapeutic Solutions
Publisher: WILEY-HINDAWIISSN: 1755-5914Frequency: 1 issue/year

Cardiovascular Therapeutics is a renowned Open Access journal, published by WILEY-HINDAWI, that has been at the forefront of advancing knowledge in the field of cardiology and cardiovascular medicine since its establishment. With a strong commitment to disseminating high-quality research, the journal has successfully positioned itself within the Q2 quartile in multiple categories, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pharmacology. The journal is indexed in Scopus, achieving impressive rankings, such as #95 out of 387 in Cardiology, and #87 out of 272 in Medical Pharmacology. Situated in the United Kingdom, Cardiovascular Therapeutics embraces an Open Access model since 2019, ensuring that groundbreaking research is accessible to researchers, practitioners, and students across the globe. The journal is dedicated to publishing original research articles, reviews, and clinical studies that contribute to the understanding and treatment of cardiovascular diseases, making it an essential resource for those invested in improving patient outcomes and advancing therapeutic strategies in this vital area of medicine.